Engineered Salmonella therapy delivers immune payloads to combat cancer
A new research paper was published in Volume 16 of Oncotarget on October 6, 2025, titled “ACTM-838, a novel systemically delivered…
α-L-fucosidase isoenzymes (FUCA1/FUCA2) as prognostic markers in gliomas: a comprehensive study | BMC Cancer
Clinical samples and ethics of study Sample acquisition: (1) Glioma tissues: 30 cases (25 grade II/III, 5 GBM;…
Highly targeted gene therapy could revolutionize treatment for cancers linked to herpesvirus
In a preclinical study, UC Davis Comprehensive Cancer Center scientists developed a highly targeted gene therapy that could…
Genetic Screening Highlighted During Pink Power Hour
MyRisk genetic screening kit that was distributed to 350 participants at the Pink Power Hour [Corinna Singleman] October…
Digital tools and chatbots can expand genetic counseling for young cancer survivors
A groundbreaking new study from the Alliance for Clinical Trials in Oncology aims to test whether digital tools…
Randomized trial finds both proton and photon therapies preserve post-treatment well-being
The first randomized trial to compare photon- and proton-based radiation therapy for breast cancer finds that patients report…
Radiation therapy shows promise as safer alternative for severe heart rhythm disorder
Radiation therapy may offer a comparable and potentially safer alternative to repeat catheter ablation for patients with severe…
Reviewing the lines of therapy-concept in cancer treatment: a survey study among physicians | BMC Cancer
Respondents’ professional background and socio-demographics As part of the data processing, two respondents were excluded because their answers…
Genetic testing guides personalized radiation patients with HPV-positive throat cancer
Genetic testing can identify patients with HPV-positive throat cancer who may benefit from lower radiation doses, according to…
UCLA presents advances in radiation therapy at ASTRO 2025
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and clinical trial results…
Novel treatment disrupts tumor immunosuppression in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a five-year survival rate below 10%. University…
Philips new CT and MR systems at ASTRO 2025
Philips expands MR leadership with helium-free BlueSeal RT [4] Alongside its newest CT innovations, Philips is introducing…